PT - JOURNAL ARTICLE AU - Wacharapluesadee, Supaporn AU - Kaewpom, Thongchai AU - Ampoot, Weenassarin AU - Ghai, Siriporn AU - Khamhang, Worrawat AU - Worachotsueptrakun, Kanthita AU - Wanthong, Phanni AU - Nopvichai, Chatchai AU - Supharatpariyakorn, Thirawat AU - Putcharoen, Opass AU - Paitoonpong, Leilani AU - Suwanpimolkul, Gompol AU - Jantarabenjakul, Watsamon AU - Hemachudha, Pasin AU - Krichphiphat, Artit AU - Buathong, Rome AU - Plipat, Tanarak AU - Hemachudha, Thiravat TI - Evaluating efficiency of pooling specimens for PCR-based detection of COVID-19 AID - 10.1101/2020.05.02.20087221 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.02.20087221 4099 - http://medrxiv.org/content/early/2020/05/06/2020.05.02.20087221.short 4100 - http://medrxiv.org/content/early/2020/05/06/2020.05.02.20087221.full AB - In the age of a pandemic, such as the ongoing one caused by SARS-CoV-2, the world faces limited supply of tests, PPE and reagents, and factories are struggling to meet the growing demands. This study aimed to evaluate the efficacy of pooling specimen for testing of SARS-CoV-2 virus, to determine whether costs and resource savings could be achieved without impacting the sensitivity of the testing. Ten specimens were pooled for testing, containing either one or two known positive specimen of varying viral concentrations. Pooling specimens did not affect the sensitivity of detecting SARS-CoV-2, and the PCR cycle threshold (Ct) between testing of pooling specimen and subsequent individual testing was not significantly different using paired t-test. This study also identified cost savings garnered from pooling of specimen for testing at 4 differing prevalence rates, ranging from 0.1-10%. Pooling specimens to test for COVID-19 infection in low prevalence areas or in low risk population can dramatically decrease the resources burden on lab operations by up to 80%. This paves the possibility for large-scale population screening, allowing for assured policy decisions by governmental bodies to ease lockdown restrictions in areas with low incidence of infection, or with lower risk populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a research grant from the King Chulalongkorn Memorial Hospital’s Excellent Center Program, National Research Council of Thailand (NRCT), and the Biological Threat Reduction Program (BTRP) of the US Defense Threat Reduction Agency (DTRA).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in this manuscript is included in the manuscript.